Figure 1
From: Sorafenib in advanced melanoma: a critical role for pharmacokinetics?

Effect of dose escalation on inter patient sorafenib AUC (mg l−1 h−1). A total 119 AUCs from 29 patients are represented. Wilcoxon’s P-value: *<0.05, **<0.005, NS >0.05.